MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuropsychiatric manifestations in Parkinson’s disease

O. Cherkaoui Rhazouani, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

Meeting: 2019 International Congress

Abstract Number: 364

Keywords: Anxiety, Depression, Dopamine

Session Information

Date: Monday, September 23, 2019

Session Title: Psychiatric Manifestations

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: Evaluate the different neuropsychiatric manifestations in Parkinson’s disease.

Background: Parkinson’s disease (PD) is the second most common neurodegenerative pathology after Alzheimer’s disease, although PD is diagnosed clinically by its motor manifestations, it could be preceded and accompanied by neuropsychiatric troubles (NPT) such as: depression, anxiety, apathy, and hallucinations.

Method: Authors realized a prospectively study about 79 patients consulting for PD in the neurology department of the Mohammed VI University Hospital of Marrakech (Morocco) over a period of four months (between March 2018 and June 2018). Information was collected using the Neuropsychiatric Inventory (NPI) and by using a questionnaire, authors have described the different NPT during ON / OFF periods.

Results: Authors collected 79 cases including 43 men and 36 women. The average age of patients was 59 years old. The mean duration of disease was 7 years. The NPTs were more common in women and the NPI show a high score for depression, anxiety and mood instability. No correlation score items were found with age, however a significant correlation was established between apathy score (p <0.05, p = 0.02), hallucination score (p <0.05, p = 0.03) and duration of evolution of the MP. Depression, anxiety and panic attacks are the most frequent during OFF periods: 58 cases (73.42%), 55 cases (69.62%) and 46 cases (58.24%) respectively with an improvement found in 51 patients for depression, 46 patients for anxiety and 33 patients for panic attacks during ON periods.

Conclusion: NPTs have a significant impact on the quality of life of Parkinson’s patients and their families. Motor improvement by dopa therapy during unblocking periods ON seems to result in significant psychic improvement during PD.

To cite this abstract in AMA style:

O. Cherkaoui Rhazouani, N. Jalami, M. Chraa, N. Kissani. Neuropsychiatric manifestations in Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/neuropsychiatric-manifestations-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuropsychiatric-manifestations-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley